GRITSTONE BIO INC(GRTSQ.US)

Company Encyclopedia

GRITSTONE BIO INC

GRTSQ.US

1.927 T

GRTSQ.USMarket value -Rank by Market Cap -/-

Financial Score

22/01/2026 Update

BiotechnologyIndustry

Industry Ranking352/398

Industry medianC

Industry averageD

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreE
- ROE-201.94%E
- Profit Margin-910.56%E
- Gross Margin-2159.61%E
Growth ScoreC
- Revenue YoY25.09%A
- Net Profit YoY-1.95%C
- Total Assets YoY-35.97%E
- Net Assets YoY-79.75%E
Cash ScoreC
- Cash Flow Margin-10.98%D
- OCF YoY25.09%A
Operating ScoreE
- Turnover0.08E
Debt ScoreE
- Gearing Ratio84.43%E

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
No Data

News

Sector Update: Health Care Stocks Rise in Afternoon Trading

Health care stocks rose in afternoon trading, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF increasing by 0.3%. The iShares Biotechnology ETF gained 1.5%. Moderna's shares rose 6.7% despite the company not planning new vaccine trials due to US opposition. Abbott Laboratories' shares fell over 9% after issuing a Q1 earnings outlook below estimates. In contrast, 60 Degrees Pharmaceuticals' shares surged 151% following a partnership announcement with Runway Health for malaria prevention.

fidelity·1 Hours ago

Study shows fecal microbiota transfer rejuvenates aging intestines in mice, leading to faster injury recovery & reduced risk of diseases.

A study conducted in Cincinnati on January 22, 2026, reveals that fecal microbiota transfer in mice can accelerate injury recovery, enhance infection resistance, and lower the risk of inflammatory bowel disease. The findings suggest that gut bacteria composition significantly impacts overall health, indicating fecal microbiota transfer as a potential method for promoting health and advancing medical treatment.

Unusual Whales·3 Hours ago

NIH Says Policy Shift To End Use Of Human Fetal Tissue In NIH-Supported Research

Jan 22 (Reuters) - NIH:* NIH: POLICY SHIFT TO END USE OF HUMAN FETAL TISSUE IN NIH-SUPPORTED RESEARCH* NIH: EFFECTIVE IMMEDIATELY, NIH FUNDS WILL NO LONGER BE USED TO SUPPORT RESEARCH INVOLVING HUMAN FETAL TISSUE FROM ELECTIVE ABORTIONS

Reuters·3 Hours ago

These Are Today’s Marketing Moving Trades

Investors are moving away from consumer packaged goods, with Berkshire Hathaway planning to sell its 27.5% stake in Kraft Heinz, which saw a 6% drop in stock price. Applovin and Oracle are also trending down, while Microsoft faces criticism over Windows 11. In contrast, Intel's stock is rising ahead of its quarterly results, and Sandisk has gained 10.5% recently. Moderna's share price is nearing a double, with significant short interest.

Baystreet·4 Hours ago

Baystreet·4 Hours ago

ICRF and CRI co-fund grant to address immunotherapy resistance in melanoma led by Asaf Madi, PhD. – Tel Aviv University.

A recent study overseen by Dr. Asaf Madi from Tel Aviv University aims to enhance the effectiveness and longevity of TIL therapy for individuals facing advanced illnesses. In an announcement made on January 22, 2026, in New York, the Israel Cancer Research Fund (ICRF) and the Cancer Research Institute (CRI) disclosed their collaboration on a fresh award. This initiative seeks to boost the reliability and durability of TIL therapy for patients, highlighting the commitment to advancing cancer treatment options.

Unusual Whales·6 Hours ago